|
|
The Personalized Health Paradigm: Transforming the Pharmaceutical and Healthcare Industries for the 21st CenturyPublished by: IDC Published: Oct. 3, 2006 - 18 Pages Table of ContentsTable of Contents Health Industry Insights Opinion In This Report Situation Overview What Is Personalized Health? Figure: From Discovery to Payer: The Contribution of Knowledge to the Personalized Health Landscape Key Stakeholders in Personalized Health Figure: Topics Driving Key Personalized Health Stakeholders Pharma Discovery Perspective Clinical Development Perspective Patient Perspective Provider Perspective Payer Perspective Drivers Supporting the Adoption of Personalized Health The Growing Wealth of Biological Data Increased Ability to Transform Data into Knowledge Increased Electronic Access to Knowledge Targeted Disease Therapeutics, Especially in Areas with High Unmet Needs Intellectual Property Enabling Development Funding Agility of Biotech Companies to Pioneer New Market Opportunities Disease Advocacy Groups (With or Without Funding or Biobank Samples) Driving Targeted Demand Broad Availability of Technology Platforms to Transform Research Discoveries into Clinical Diagnostic Tools Decreased Downstream Costs Expected Barriers to the Adoption of Personalized Health Reduced Market Sizes Transforming Pharmaceutical Industry Momentum from the Blockbuster Model Unequal Distribution of Cost/Benefits for Innovative Healthcare Delivery (e.g., Remote Health Monitoring, Email Patient/Physician Interactions) Concerns over Personal Healthcare Information Privacy and Security/Patient Confidentiality Premium Pricing for Orphan or Other Novel Therapeutics Intellectual Property Concerns Future Outlook Industry Impact of Personalized Health For the Life Science Industry For Clinical Development For Patients For Providers For Payers Areas to Watch for Key Milestones Indicating Progress Essential Guidance Actions to Consider The Pharmaceutical and Biotechnology Industries Clinical Development Healthcare Providers Healthcare Payers Learn More Related Research Synopsis AbstractThis Health Industry Insights report examines the emerging area of personalized health. This report provides a foundation for future discussions by defining the landscape, identifying the major drivers and barriers to adoption, anticipating how personalized health will impact the major stakeholders in both the life science and healthcare value chains, and recognizing likely indicators that track adoption. This and future reports provide actionable strategic insights that pharmaceutical companies, supporting industries, healthcare providers, and healthcare payers should consider during the anticipated transformation of the life science and healthcare industries toward personalized health. "The anticipated loss of the traditional blockbuster model, the shift toward outcomes-based medicine, and the strong need for restraint in healthcare costs is forcing a shift toward knowledge-based personalized health solutions that is beginning now. The signs are there if you know where to look," said Alan Louie, Ph.D., research director for Health Industry Insights. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||